IMMUNE-MEDIATED KIDNEY DISEASE IN 2017: Progress in mechanisms and therapy for immunological kidney disease

    loading  Checking for direct PDF access through Ovid

Abstract

In 2017, progress was made in several aspects of immune-mediated kidney disease. Mechanistic studies provided new insights into the underlying signals that confer risk to, or protection from, immune pathways, whereas new approaches to the treatment of immunological kidney disease will hopefully translate into a move away from the use of toxic corticosteroids.

Related Topics

    loading  Loading Related Articles